Showing 1 - 10 of 14
For a full text file please contact the corresponding author: Kenth Skogsvik (E-mail: kenth.skogsvik@hhs.se).
Persistent link: https://www.econbiz.de/10008869313
Using Swedish stock market data, this study investigates whether an investment strategy based on publicly available accounting information can generate abnormal investment returns. The strategy involves two steps. First, an accounting-based probabilistic prediction model of changes in the...
Persistent link: https://www.econbiz.de/10008740358
Persistent link: https://www.econbiz.de/10010543783
In the abnormal earnings growth (AEG) model of Ohlson and Juettner-Nauroth (2005), there is one interest rate and no taxes. Their model focuses on bottom-line earnings and dividends and is hence viewed as an equity-level model. We first extend this model to a firm-level model based on operating...
Persistent link: https://www.econbiz.de/10005802498
Using Swedish data, the study investigates whether an investment strategy based on publicly available financial statement information can generate abnormal investment returns. The strategy involves two steps. First, a financial statement based prediction model of changes in the book return on...
Persistent link: https://www.econbiz.de/10005839410
Relative P/E-ratio valuation apparently still plays an important role among investment research analysts and advisors (cf. Goldman Sachs,1999). In a valuation model of this kind, the value of owners´equity is typically calculated as a function of an observed P/E-ratio for some peer company, or...
Persistent link: https://www.econbiz.de/10005839412
The disclosure behaviour for a sample of quoted Swedish and UK pharmaceutical companies is investigated in the paper. The sample consists of three Swedish (Astra, Gambro and Pharmacia) and three UK (Glaxo, SmithKline Beecham and Wellcome) pharmaceutical companies, whose annual financial reports...
Persistent link: https://www.econbiz.de/10005639908
In order to enhance our understanding of the content and context of voluntary disclosures, the disclosure behaviour of a sample of Swedish and UK pharmaceutical companies is investigated in this paper. The investigation has been guided by a fundamental ("residual income") valuation model, based...
Persistent link: https://www.econbiz.de/10005626803
Persistent link: https://www.econbiz.de/10005676897
Persistent link: https://www.econbiz.de/10009175462